Edwards Lifesciences (EW) Tops Q2 EPS by 20c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Edwards Lifesciences (EW) Tops Q2 EPS by 20c; Raises Outlook

Edwards Lifesciences (EW) PT Raised to $155 at Canaccord Genuity on 2Q Beat; 'Keep Buying... Upside to Raised Guidance in the Cards'

July 27, 2017 10:48 AM EDT

Canaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $155.00 (from $150.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.

Analyst Jason Mills notes the company delivered a second quarter earnings per share and revenue results above consensus projections... More

Edwards Lifesciences (EW) PT Raised to $130 at Stifel; Reiterates Buy

July 27, 2017 8:30 AM EDT

Stifel raised its price target on Edwards Lifesciences (NYSE: EW) to $130.00 (from $118.00) while maintaining a Buy rating. For 3Q17, the company anticipates revenue between $810M-$850M with EPS at $0.80-$0.90 (mid-point: $0.85).

For 2017, Edwards now expects full-year revenue at the higher end of the $3.2 billion... More

Edwards Lifesciences (EW) PT Raised to $132 at Jefferies

July 27, 2017 7:33 AM EDT

Jefferies raised its price target on Edwards Lifesciences (NYSE: EW) to $132.00 (from $115.00) while maintaining a Buy rating following the company's 2Q. EW put up another impressive TAVR Q with +23.3% underlying y/y growth and +7% growth sequentially. After adding back $22.5mn of German inventory... More